Aralez Pharmaceuticals Inc. 4

4 · Aralez Pharmaceuticals Inc. · Filed Jun 20, 2016

Form 4

Period: 2016-06-16

Director

Transactions

Award
Employee Stock Option (right to buy)
2016-06-16+15,000→ 15,000 total
Exercise: $3.42Exp: 2026-06-16→ Common Shares, without par value (15,000 underlying)
Award
Common Shares, without par value
2016-06-16+7,500→ 11,865 total

Holdings

Footnotes (5)

[F1]Restricted Stock Units, all of which vest on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.
[F2]Includes 4,365 shares of Common Stock and 7,500 Restricted Stock Units.
[F3]Due to a clerical error on the Reporting Person's Form 4, dated as of June 15, 2016, the amount of securities directly beneficially owned by the Reporting Person was incorrectly reported as 277,178 (which reflected the combined amount of securities directly and indirectly owned by the Reporting Person) rather than 4,365. This Form 4 reflects the correct amount of directly beneficially owned securities and indirectly owned securities, properly reported as separate line items.
[F4]The Reporting Person is the sole owner and president of 2089636 Ontario Ltd.
[F5]The option vests in one installment on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.

Documents

1 file